Sales and Marketing

News

GSK rides out vaccine sales weakness with cancer, HIV gains

Despite a steep fall-off in sales of RSV vaccine Arexvy last year, GSK has raised its long-term sales forecast to £40 billion in 2031.

News

Novo rises on Wegovy sales leap, but warns of a slowdown

Novo Nordisk is expecting greater competition and pricing pressure in the obesity and diabetes sectors this year.

News

Lyfegen partners EVERSANA on pricing, access resource

Lyfegen and EVERSANA have joined forces to help pharma companies navigate an increasingly complex global drug pricing and access environment.

News

Lilly trims sales forecast on weaker obesity/diabetes growth

Eli Lilly has revised its revenue forecast for 2024 after seeing weaker-than-expected growth for its diabetes and obesity therapies.

News

Scrabble letters spelling out 'Deep Breath'

Verona says COPD drug is off to a flying start

Verona Pharma's plans to transform COPD treatment with recently approved Ohtuvayre look like they are on course, given early sales figures.

News

Four drugmakers found to have breached ABPI code

Novartis, Pfizer, Otsuka and Novo Nordisk have been called out by the UK’s Prescription Medicines Code of Practice Authority (PMCPA) for breaching the Association of the British Pharmaceuti

GSK rides out vaccine sales weakness with cancer, HIV gains

Novo rises on Wegovy sales leap, but warns of a slowdown

Lyfegen partners EVERSANA on pricing, access resource

Lilly trims sales forecast on weaker obesity/diabetes growth

Verona says COPD drug is off to a flying start

Four drugmakers found to have breached ABPI code

Lilly bags FDA okay for Wegovy pill rival orforglipron

Using AI-driven synthetic personas to take your insights fur...

Sales and Marketing

Editor's Picks